Clinical Trial: A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: An Open-Label, Long-Term Safety Study of Long-acting Human Growth Hormone Somavaratan (VRS-317) in Japanese Children With Growth Hormone Deficiency

Brief Summary: This study is a multi-center, open-label safety study assessing long-term somavaratan administration.